JP2010053135A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010053135A5 JP2010053135A5 JP2009272679A JP2009272679A JP2010053135A5 JP 2010053135 A5 JP2010053135 A5 JP 2010053135A5 JP 2009272679 A JP2009272679 A JP 2009272679A JP 2009272679 A JP2009272679 A JP 2009272679A JP 2010053135 A5 JP2010053135 A5 JP 2010053135A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- symptom
- neutropenia
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000004235 neutropenia Diseases 0.000 claims description 10
- 210000000130 stem cell Anatomy 0.000 claims description 4
- 238000011282 treatment Methods 0.000 claims description 4
- 238000010322 bone marrow transplantation Methods 0.000 claims description 3
- 210000001185 bone marrow Anatomy 0.000 claims description 2
- 208000015181 infectious disease Diseases 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 23
- 208000024891 symptom Diseases 0.000 claims 11
- 150000001875 compounds Chemical class 0.000 claims 9
- 206010065553 Bone marrow failure Diseases 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 238000001959 radiotherapy Methods 0.000 claims 3
- 102000004127 Cytokines Human genes 0.000 claims 2
- 108090000695 Cytokines Proteins 0.000 claims 2
- 238000002512 chemotherapy Methods 0.000 claims 2
- 208000014674 injury Diseases 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 230000008733 trauma Effects 0.000 claims 2
- 208000019838 Blood disease Diseases 0.000 claims 1
- 108010071942 Colony-Stimulating Factors Proteins 0.000 claims 1
- 102000007644 Colony-Stimulating Factors Human genes 0.000 claims 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims 1
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims 1
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims 1
- 101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 102000003812 Interleukin-15 Human genes 0.000 claims 1
- 108090000172 Interleukin-15 Proteins 0.000 claims 1
- 102000000588 Interleukin-2 Human genes 0.000 claims 1
- 108010002350 Interleukin-2 Proteins 0.000 claims 1
- 208000002720 Malnutrition Diseases 0.000 claims 1
- 235000014113 dietary fatty acids Nutrition 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 229930195729 fatty acid Natural products 0.000 claims 1
- 239000000194 fatty acid Substances 0.000 claims 1
- -1 fatty acid triglycerides Chemical class 0.000 claims 1
- 208000014951 hematologic disease Diseases 0.000 claims 1
- 208000018706 hematopoietic system disease Diseases 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 235000018343 nutrient deficiency Nutrition 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 230000001052 transient effect Effects 0.000 claims 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 claims 1
- 238000004904 shortening Methods 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28445801P | 2001-04-18 | 2001-04-18 | |
| US60/284,458 | 2001-04-18 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002580924A Division JP5026655B2 (ja) | 2001-04-18 | 2002-04-18 | 好中球の生存及び活性化因子としての中鎖脂肪酸、グリセリド及び類似体 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014165557A Division JP6420089B2 (ja) | 2001-04-18 | 2014-08-15 | 好中球の生存及び活性化因子としての中鎖脂肪酸、グリセリド及び類似体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010053135A JP2010053135A (ja) | 2010-03-11 |
| JP2010053135A5 true JP2010053135A5 (enExample) | 2014-01-16 |
| JP5657879B2 JP5657879B2 (ja) | 2015-01-21 |
Family
ID=23090294
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002580924A Expired - Lifetime JP5026655B2 (ja) | 2001-04-18 | 2002-04-18 | 好中球の生存及び活性化因子としての中鎖脂肪酸、グリセリド及び類似体 |
| JP2009272679A Expired - Lifetime JP5657879B2 (ja) | 2001-04-18 | 2009-11-30 | 好中球の生存及び活性化因子としての中鎖脂肪酸、グリセリド及び類似体 |
| JP2014165557A Expired - Lifetime JP6420089B2 (ja) | 2001-04-18 | 2014-08-15 | 好中球の生存及び活性化因子としての中鎖脂肪酸、グリセリド及び類似体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002580924A Expired - Lifetime JP5026655B2 (ja) | 2001-04-18 | 2002-04-18 | 好中球の生存及び活性化因子としての中鎖脂肪酸、グリセリド及び類似体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014165557A Expired - Lifetime JP6420089B2 (ja) | 2001-04-18 | 2014-08-15 | 好中球の生存及び活性化因子としての中鎖脂肪酸、グリセリド及び類似体 |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US7745488B2 (enExample) |
| EP (2) | EP1900364B1 (enExample) |
| JP (3) | JP5026655B2 (enExample) |
| KR (1) | KR20030096323A (enExample) |
| CN (1) | CN1633286A (enExample) |
| AP (1) | AP1740A (enExample) |
| AU (2) | AU2002308456B2 (enExample) |
| BG (1) | BG66418B1 (enExample) |
| BR (1) | BR0208984A (enExample) |
| CA (2) | CA2444463C (enExample) |
| CY (1) | CY1107081T1 (enExample) |
| CZ (1) | CZ305273B6 (enExample) |
| DE (1) | DE60223670T2 (enExample) |
| DK (2) | DK1900364T3 (enExample) |
| EA (1) | EA007322B1 (enExample) |
| EE (1) | EE200300510A (enExample) |
| ES (2) | ES2295397T3 (enExample) |
| HU (1) | HUP0303817A3 (enExample) |
| IL (3) | IL158322A0 (enExample) |
| MX (1) | MXPA03009436A (enExample) |
| NO (1) | NO335105B1 (enExample) |
| NZ (2) | NZ528690A (enExample) |
| OA (1) | OA12506A (enExample) |
| PL (2) | PL222876B1 (enExample) |
| PT (2) | PT1900364E (enExample) |
| SI (1) | SI1385498T1 (enExample) |
| SK (1) | SK12772003A3 (enExample) |
| TN (1) | TNSN03089A1 (enExample) |
| WO (1) | WO2002083120A2 (enExample) |
| ZA (1) | ZA200307778B (enExample) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5026655B2 (ja) | 2001-04-18 | 2012-09-12 | プロメティック、バイオサイエンシーズ、インコーポレーテッド | 好中球の生存及び活性化因子としての中鎖脂肪酸、グリセリド及び類似体 |
| ES2255467T3 (es) * | 2003-02-07 | 2009-05-01 | Prometic Biosciences Inc. | Acidos grasos de cadena de longitud media, gliceridos y analogos como estimuladores de eritropoyesis. |
| EA010021B1 (ru) | 2003-07-25 | 2008-06-30 | Прометик Байосайенсиз, Инк. | Способ получения металлических солей среднецепочечных жирных кислот |
| US20070219131A1 (en) * | 2004-04-15 | 2007-09-20 | Ben-Sasson Shmuel A | Compositions capable of facilitating penetration across a biological barrier |
| KR20070044805A (ko) * | 2004-04-15 | 2007-04-30 | 키아스마, 인코포레이티드 | 생물학적 장벽 투과를 촉진시킬 수 있는 조성물 |
| JP2008511553A (ja) * | 2004-09-03 | 2008-04-17 | プロメティック バイオサイエンシズ インコーポレーテッド | 免疫調節活性および化学防護活性を有する置換型プリニル誘導体ならびにその単独使用または中鎖長の脂肪酸もしくはグリセリドとの併用 |
| US8071580B2 (en) * | 2004-10-01 | 2011-12-06 | Prometic Biosciences Inc. | Medium-chain length fatty alcohols as stimulators of hematopoiesis |
| PT1804780E (pt) * | 2004-10-01 | 2012-01-19 | Prometic Biosciences Inc | Álcoois gordos com comprimento médio da cadeia como estimuladores da hematopoiese |
| EP1858912B1 (en) * | 2005-02-28 | 2012-04-11 | Alphabeta AB | Compounds for reducing aggregation of amyloid beta-peptide |
| ES2601845T3 (es) * | 2006-05-17 | 2017-02-16 | Cognate Therapeutics, Inc. | Aislamiento y purificación de células madre hematopoyéticas a partir de lipoaspirados post-liposucción |
| DK2180787T3 (da) | 2007-08-01 | 2014-02-03 | Univ Pittsburgh | Nitrooliesyremodulering af type ii-diabetes |
| RU2519215C2 (ru) * | 2007-11-02 | 2014-06-10 | Прометик Байосайенсиз Инк. | Жирные кислоты и глицериды со средней длиной цепи в качестве нефропротективных средств |
| WO2009076761A1 (en) * | 2007-12-19 | 2009-06-25 | Prometic Biosciences Inc. | Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer |
| JP2011519373A (ja) | 2008-05-01 | 2011-07-07 | コンプレクザ インコーポレイテッド | ビニル置換脂肪酸 |
| EP2299997A4 (en) * | 2008-06-19 | 2012-01-11 | Univ Utah Res Found | USE OF NITRATED LIPIDS FOR THE TREATMENT OF SIDE EFFECTS OF TOXIC MEDICAL THERAPIES |
| US20140024713A1 (en) | 2008-06-19 | 2014-01-23 | University Of Utah Research Foundation | Use of nitrated lipids for treatment of side effects of toxic medical therapies |
| KR101814186B1 (ko) | 2008-09-17 | 2018-03-14 | 키아스마 인코포레이티드 | 약제학적 조성물 및 연관된 투여방법 |
| EP2165713B1 (en) * | 2008-09-19 | 2012-11-14 | Nestec S.A. | Whey and thymus function |
| US9066902B2 (en) | 2009-07-31 | 2015-06-30 | University of Pittsburgh—of the Commonwealth System of Higher Education | Fatty acids as anti-inflammatory agents |
| WO2011041639A2 (en) | 2009-10-02 | 2011-04-07 | Miller Raymond A | Heteroatom containing substituted fatty acids |
| EP2394636B1 (en) * | 2010-05-28 | 2014-03-19 | Novagali Pharma S.A. | Method for treating retinal conditions using an intraocular tamponade |
| EP2744491B1 (en) | 2011-08-19 | 2020-07-29 | The University of Utah Research Foundation | Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system |
| TWI572352B (zh) * | 2012-03-01 | 2017-03-01 | 波麥堤克藥學Ｓｍｔ有限公司 | 用於製備具中鏈長度之脂肪酸的三酸甘油酯之方法 |
| WO2013169355A1 (en) | 2012-05-09 | 2013-11-14 | Paringenix, Inc. | Treatment of myelosuppression |
| ES2751495T3 (es) | 2013-08-19 | 2020-03-31 | Enzychem Lifesciences Corp | Composiciones que contienen un compuesto monoacetildiglicérido como un componente activo para prevenir o tratar la artritis reumatoide |
| TW201609086A (zh) * | 2014-05-15 | 2016-03-16 | 安塞全生命科學公司 | 白血球減少症和血小板減少症之治療方法 |
| ES3029566T3 (en) | 2015-02-03 | 2025-06-24 | Amryt Endo Inc | Treating acromegaly with oral octreotide |
| WO2016133910A1 (en) | 2015-02-17 | 2016-08-25 | Cantex Pharmaceuticals, Inc. | Treatment of cancers and hematopoietic stem cell disorders privileged by cxcl12-cxcr4 interaction |
| HRP20210543T1 (hr) | 2015-07-07 | 2021-05-14 | H. Lundbeck A/S | Inhibitori pde9 s imidazo triazinonskom okosnicom i imidazo pirazinonskom okosnicom za liječenje perifernih bolesti |
| MX2018004043A (es) | 2015-10-02 | 2018-11-09 | Complexa Inc | Prevencion, tratamiento y reversion de enfermedad usando cantidades terapeuticamente efectivas de acidos grasos activados. |
| US9808438B2 (en) * | 2015-11-09 | 2017-11-07 | Enzychem Lifesciences Corporation | Method for treating mucositis |
| MX382853B (es) | 2016-04-22 | 2025-03-13 | Spoke Sciences Inc | Compuestos medicinales y suplementos nutricionales de base vegetal de rápida acción. |
| EP3468551A4 (en) | 2016-06-08 | 2020-01-22 | Sunregen Healthcare AG | LIPIDS WITH ODD NUMBER OF CARBON ATOMS AND THEIR USE AS A PHARMACEUTICAL COMPOSITION OR A FOOD SUPPLEMENT |
| EA201892396A1 (ru) | 2016-12-02 | 2019-04-30 | Ресептор Лайф Сайенсиз, Инк. | Быстродействующие растительные лекарственные соединения и биологически активные добавки |
| CN107382710B (zh) * | 2017-08-19 | 2020-11-06 | 中国铁道科学研究院集团有限公司铁道建筑研究所 | 一种接枝抗氧剂分子的多元醇 |
| EA202090566A1 (ru) * | 2017-09-12 | 2020-07-14 | Санреджен Хэлскэр Аг | Липиды, содержащие нечетное количество атомов углерода, и их применение в качестве фармацевтической композиции или питательной добавки |
| US20200254041A1 (en) * | 2017-10-05 | 2020-08-13 | Receptor Holdings, Inc. | Rapid onset and extended action plant-based and synthetic cannabinoid formulations |
| US20200268821A1 (en) * | 2017-10-05 | 2020-08-27 | Receptor Holdings, Inc. | Herbal compositions with improved bioavailability |
| KR102054401B1 (ko) * | 2018-03-26 | 2019-12-10 | 주식회사 엔지켐생명과학 | 1,2-디아실글리세롤 화합물, 그 제조방법 및 이를 유효성분으로 함유하는 면역조절제 |
| CN112469413B (zh) | 2018-05-25 | 2024-01-12 | 伊马拉公司 | 6-[(3s,4s)-4-甲基-1-(嘧啶-2-基甲基)吡咯烷-3-基]-3-四氢吡喃-4-基-7h-咪唑并[1,5-a]吡嗪-8-酮的一水合物和结晶形态 |
| EP3843737A4 (en) | 2018-08-31 | 2022-06-01 | Imara Inc. | PDE9 INHIBITORS FOR THE TREATMENT OF SICKLE CELL DISEASE |
| CA3112073A1 (en) | 2018-10-11 | 2020-04-16 | Basf As | Aromatic compounds and pharmaceutical uses thereof |
| AU2019385420A1 (en) | 2018-11-19 | 2021-07-08 | Spoke Sciences, Inc. | N-acylated fatty amino acids to reduce absorption variability in cannabinoid based compositions |
| KR102787675B1 (ko) * | 2019-10-31 | 2025-03-26 | 니폰 제온 가부시키가이샤 | 전기 화학 소자용 기능층 및 그 제조 방법, 전기 화학 소자용 기능층 형성 세퍼레이터 및 그 제조 방법, 그리고 전기 화학 소자 및 그 제조 방법 |
| US11141457B1 (en) | 2020-12-28 | 2021-10-12 | Amryt Endo, Inc. | Oral octreotide therapy and contraceptive methods |
| JP2024537906A (ja) * | 2021-10-18 | 2024-10-16 | エンジーケム ライフサイエンシーズ コーポレーション | 粘膜炎を処置するための組成物及び方法 |
| CN119421865A (zh) * | 2022-04-21 | 2025-02-11 | 默沙东有限责任公司 | 制备附聚的结晶中链脂肪酸钠盐的方法 |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2006A (en) * | 1841-03-16 | Clamp for crimping leather | ||
| US2002A (en) * | 1841-03-12 | Tor and planter for plowing | ||
| US2004A (en) * | 1841-03-12 | Improvement in the manner of constructing and propelling steam-vessels | ||
| US2003A (en) * | 1841-03-12 | Improvement in horizontal windivhlls | ||
| US2008A (en) * | 1841-03-18 | Gas-lamp eok conducting gas pkom ah elevated buhner to one below it | ||
| US4528197A (en) * | 1983-01-26 | 1985-07-09 | Kabivitrum Ab | Controlled triglyceride nutrition for hypercatabolic mammals |
| US4703062A (en) * | 1984-01-16 | 1987-10-27 | Baxter Travenol Laboratories, Inc. | Parenteral nutrition with medium and long chain triglycerides |
| US4871768A (en) * | 1984-07-12 | 1989-10-03 | New England Deaconess Hospital Corporation | Dietary supplement utilizing ω-3/medium chain trigylceride mixtures |
| US4816440A (en) * | 1985-09-26 | 1989-03-28 | Cetus Corporation | Stable formulation of biologically active proteins for parenteral injection |
| US7307166B1 (en) * | 1987-10-28 | 2007-12-11 | Wellstat Therapeutics Corporation | Oxpurine nucleosides and their congeners, and acyl, derivatives thereof, for improvement of hematopoiesis |
| US5011852A (en) * | 1988-07-25 | 1991-04-30 | Applied Analytical Industries, Inc. | Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs |
| JPH02134326A (ja) * | 1988-11-14 | 1990-05-23 | Snow Brand Milk Prod Co Ltd | 高度侵襲用経腸栄養剤 |
| JP3249147B2 (ja) * | 1990-06-01 | 2002-01-21 | キリン−アムジエン・インコーポレーテツド | 生理活性蛋白含有経口製剤 |
| EP0526630A4 (en) * | 1991-02-22 | 1993-08-11 | Amgen Inc. | Use of gm-csf and g-csf to promote accelerated wound healing |
| JP3132085B2 (ja) * | 1991-09-06 | 2001-02-05 | ウェルファイド株式会社 | 脂肪乳剤 |
| JPH05163160A (ja) * | 1991-12-13 | 1993-06-29 | Snow Brand Milk Prod Co Ltd | 免疫低下に伴う感染症の予防及び治療用栄養剤 |
| US5214035A (en) * | 1992-04-16 | 1993-05-25 | Hoechst-Roussel Agri-Vet Company | Thixotropic formulations |
| US5308832A (en) * | 1992-07-27 | 1994-05-03 | Abbott Laboratories | Nutritional product for persons having a neurological injury |
| US5318781A (en) * | 1993-04-06 | 1994-06-07 | Hoffmann-La Roche Inc. | Absorption enhancement of antibiotics |
| US20010003739A1 (en) * | 1993-06-24 | 2001-06-14 | Astrazeneca Ab | Systemic administration of a therapeutic preparation |
| US5631219A (en) * | 1994-03-08 | 1997-05-20 | Somatogen, Inc. | Method of stimulating hematopoiesis with hemoglobin |
| WO1995030413A1 (en) * | 1994-05-10 | 1995-11-16 | The Kitasato Institute | Hematopoietic stem cell proliferation accelerator |
| US5470861A (en) * | 1994-08-04 | 1995-11-28 | Hoffmann-La Roche Inc. | Method of promoting hair growth |
| US5549905A (en) * | 1994-10-18 | 1996-08-27 | Clintec Nutrition Co. | Enternal composition for pediatric patients |
| JPH08208510A (ja) | 1994-11-03 | 1996-08-13 | F Hoffmann La Roche Ag | インターフェロン組成物 |
| GB9516268D0 (en) * | 1995-08-08 | 1995-10-11 | Danbiosyst Uk | Compositiion for enhanced uptake of polar drugs from the colon |
| US5733884A (en) * | 1995-11-07 | 1998-03-31 | Nestec Ltd. | Enteral formulation designed for optimized wound healing |
| CA2236422C (en) * | 1995-11-28 | 2002-11-19 | B. Braun Melsungen Ag | Hydrolysis-optimized lipid emulsions and use thereof |
| AUPN933396A0 (en) * | 1996-04-17 | 1996-05-09 | Pfizer Pty Limited | Non-aqueuos oral-drench compositions containing avermectin compounds |
| US5851534A (en) * | 1996-05-03 | 1998-12-22 | Dynagen, Inc. | Methods for prevention and/or treatment of neutropenia |
| JPH10265380A (ja) | 1997-03-17 | 1998-10-06 | Bristol Myers Squibb Co | 抗ガン剤 |
| US6017531A (en) * | 1997-06-02 | 2000-01-25 | W. R. Grace & Co. | Hydrophilic composition containing protease produced by Vibrio |
| CA2303200A1 (en) | 1997-09-04 | 1999-03-11 | Brian C. Keller | Oral liposomal delivery system |
| CA2311124A1 (en) * | 1997-11-19 | 1999-05-27 | Hercules Incorporated | Fluidized polymer suspensions of cationic polysaccharides in emollients and use thereof in preparing personal care compositions |
| EP1061932B1 (en) * | 1997-11-20 | 2006-01-25 | Gil Ja Jhon | Pharmaceutical composition containing extracts of cervus nippon antlers having growth-stimulating activities of hematopoietic stem cells and megakaryocytes |
| DE69910183T2 (de) | 1998-03-11 | 2004-06-03 | Grelan Pharmaceutical Co., Ltd., Hamura | Darmlösliche sprudelnde zusammensetzungen |
| US6267985B1 (en) * | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
| BR0014320A (pt) * | 1999-09-27 | 2002-05-28 | Sonus Pharma Inc | Composições de substâncias terapêuticas solúveis em tocol |
| US6835750B1 (en) * | 2000-05-01 | 2004-12-28 | Accera, Inc. | Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II |
| AU2001264079A1 (en) | 2000-06-14 | 2001-12-24 | William Leslie Porter | Lipids for modulating immune response |
| PT1294371E (pt) * | 2000-06-20 | 2005-05-31 | Nutrition Sciences | Acidos gordos de cadeia media utilizaveis como agentes anti-microbianos |
| US6967028B2 (en) * | 2000-07-31 | 2005-11-22 | Mainelab | Prolonged release microspheres for injectable administration |
| IL142535A0 (en) | 2001-04-11 | 2002-03-10 | Yeda Res & Dev | Pharmaceutical compositions for the treatment of inflammation |
| JP5026655B2 (ja) | 2001-04-18 | 2012-09-12 | プロメティック、バイオサイエンシーズ、インコーポレーテッド | 好中球の生存及び活性化因子としての中鎖脂肪酸、グリセリド及び類似体 |
| US20040052836A1 (en) | 2002-09-13 | 2004-03-18 | Li Luk Chiu | Pharmaceutical compositions containing at least one stable liposphere having an improved shelf life |
| ES2255467T3 (es) * | 2003-02-07 | 2009-05-01 | Prometic Biosciences Inc. | Acidos grasos de cadena de longitud media, gliceridos y analogos como estimuladores de eritropoyesis. |
| US6725510B1 (en) * | 2003-04-25 | 2004-04-27 | Almetta Clyburn | Inclining coffin |
| EA010021B1 (ru) | 2003-07-25 | 2008-06-30 | Прометик Байосайенсиз, Инк. | Способ получения металлических солей среднецепочечных жирных кислот |
| JP2008511553A (ja) * | 2004-09-03 | 2008-04-17 | プロメティック バイオサイエンシズ インコーポレーテッド | 免疫調節活性および化学防護活性を有する置換型プリニル誘導体ならびにその単独使用または中鎖長の脂肪酸もしくはグリセリドとの併用 |
| US8071580B2 (en) * | 2004-10-01 | 2011-12-06 | Prometic Biosciences Inc. | Medium-chain length fatty alcohols as stimulators of hematopoiesis |
-
2002
- 2002-04-18 JP JP2002580924A patent/JP5026655B2/ja not_active Expired - Lifetime
- 2002-04-18 DK DK07116425.5T patent/DK1900364T3/da active
- 2002-04-18 NZ NZ528690A patent/NZ528690A/en not_active IP Right Cessation
- 2002-04-18 EA EA200301131A patent/EA007322B1/ru not_active IP Right Cessation
- 2002-04-18 CA CA2444463A patent/CA2444463C/en not_active Expired - Lifetime
- 2002-04-18 CA CA2763637A patent/CA2763637C/en not_active Expired - Lifetime
- 2002-04-18 ES ES02761857T patent/ES2295397T3/es not_active Expired - Lifetime
- 2002-04-18 KR KR10-2003-7013555A patent/KR20030096323A/ko not_active Ceased
- 2002-04-18 CZ CZ2003-2685A patent/CZ305273B6/cs not_active IP Right Cessation
- 2002-04-18 EP EP07116425.5A patent/EP1900364B1/en not_active Expired - Lifetime
- 2002-04-18 EE EEP200300510A patent/EE200300510A/xx unknown
- 2002-04-18 AP APAP/P/2003/002888A patent/AP1740A/en active
- 2002-04-18 WO PCT/CA2002/000535 patent/WO2002083120A2/en not_active Ceased
- 2002-04-18 SK SK1277-2003A patent/SK12772003A3/sk unknown
- 2002-04-18 PT PT71164255T patent/PT1900364E/pt unknown
- 2002-04-18 MX MXPA03009436A patent/MXPA03009436A/es active IP Right Grant
- 2002-04-18 HU HU0303817A patent/HUP0303817A3/hu unknown
- 2002-04-18 DK DK02761857T patent/DK1385498T3/da active
- 2002-04-18 PT PT02761857T patent/PT1385498E/pt unknown
- 2002-04-18 OA OA1200300273A patent/OA12506A/en unknown
- 2002-04-18 US US10/475,266 patent/US7745488B2/en not_active Expired - Lifetime
- 2002-04-18 ES ES07116425.5T patent/ES2439738T3/es not_active Expired - Lifetime
- 2002-04-18 PL PL402948A patent/PL222876B1/pl unknown
- 2002-04-18 EP EP02761857A patent/EP1385498B1/en not_active Expired - Lifetime
- 2002-04-18 SI SI200230655T patent/SI1385498T1/sl unknown
- 2002-04-18 PL PL366435A patent/PL223348B1/pl unknown
- 2002-04-18 BR BR0208984-0A patent/BR0208984A/pt not_active Application Discontinuation
- 2002-04-18 AU AU2002308456A patent/AU2002308456B2/en not_active Expired
- 2002-04-18 CN CNA028094263A patent/CN1633286A/zh active Pending
- 2002-04-18 NZ NZ541140A patent/NZ541140A/en not_active IP Right Cessation
- 2002-04-18 DE DE60223670T patent/DE60223670T2/de not_active Expired - Lifetime
- 2002-04-18 IL IL15832202A patent/IL158322A0/xx active IP Right Grant
-
2003
- 2003-07-08 TN TNPCT/CA2002/000535A patent/TNSN03089A1/en unknown
- 2003-10-06 ZA ZA200307778A patent/ZA200307778B/en unknown
- 2003-10-09 IL IL158322A patent/IL158322A/en unknown
- 2003-10-17 NO NO20034644A patent/NO335105B1/no not_active IP Right Cessation
- 2003-10-17 BG BG108280A patent/BG66418B1/bg unknown
-
2006
- 2006-03-21 AU AU2006201163A patent/AU2006201163B2/en not_active Expired
-
2007
- 2007-12-12 CY CY20071101574T patent/CY1107081T1/el unknown
-
2008
- 2008-11-10 IL IL195200A patent/IL195200A/en active IP Right Grant
-
2009
- 2009-11-30 JP JP2009272679A patent/JP5657879B2/ja not_active Expired - Lifetime
-
2010
- 2010-06-11 US US12/814,028 patent/US8487001B2/en not_active Expired - Fee Related
-
2014
- 2014-08-15 JP JP2014165557A patent/JP6420089B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010053135A5 (enExample) | ||
| JP6212765B2 (ja) | 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤 | |
| JP2012526850A5 (enExample) | ||
| EP2275107A3 (en) | Combinations for the treatment of diseases involving cell proliferation | |
| RU2016149232A (ru) | Способы лечения лейкопении и тромбоцитопении | |
| JP2013545730A5 (enExample) | ||
| CA2455559A1 (en) | Methods to mobilize progenitor/stem cells | |
| JP2010507567A5 (enExample) | ||
| RU2011127079A (ru) | Комбинация производного циклоспорина и нуклеозидов для лечения инфекции вирусом гепатита с | |
| RU2018120318A (ru) | ИМИДАЗО[4,5-c]ХИНОЛИН-2-ОНОВЫЕ СОЕДИНЕНИЯ И ИХ ПРИМЕНЕНИЕ В ЛЕЧЕНИИ РАКА | |
| JP2011530545A5 (enExample) | ||
| JP2011516511A5 (enExample) | ||
| JP2012522841A5 (enExample) | ||
| CA2526244A1 (en) | Pharmaceutical combination of g-csf and plgf useful for blood stem cell mobilization | |
| CN114732807A (zh) | 米托蒽醌在制备预防或治疗急性移植物抗宿主病药物中的应用 | |
| JP2012518671A5 (enExample) | ||
| CN104415332A (zh) | 异硫氰酸酯类化合物与激酶抑制剂类药物在癌症治疗中的联合应用 | |
| CN103251741A (zh) | 一种治疗猪弓形虫病的中药组合物及其制备方法和应用 | |
| CN103622988A (zh) | 虫草素在制备抗抑郁症的药物中的用途及其制备而得的快速抗抑郁症药物 | |
| CN101080229A (zh) | 免疫调节剂取代的嘌呤基衍生物和其化学保护活性以及其单独使用或与中链脂肪酸或甘油酯联用的用途 | |
| CN104622874B (zh) | Ccr4拮抗剂在抑制癌生长及转移中的应用 | |
| JP2014530200A5 (enExample) | ||
| RU2012114023A (ru) | Способ стимуляции эндогенной продукции цитокинов и гемопоэтических факторов | |
| CN104117064A (zh) | 异硫氰酸酯类化合物与激素类药物的联合应用 | |
| WO2011052919A3 (ko) | 신규 알파-갈락토실세라마이드 유도체, 이의 약학적으로 허용 가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 면역보조용 약학적 조성물 |